Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …

Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder characterized
by abdominal pain and discomfort in association with altered bowel habits. It is estimated to …

Irritable bowel syndrome (IBS) causes gastrointestinal symptoms such as abdominal pain,
bloating, and bowel pattern abnormalities, which compromise patients' daily functioning …

Irritable bowel syndrome (IBS) is a highly prevalent functional disorder that reduces patients'
quality of life. It is a chronic disorder characterized by abdominal pain or discomfort …

Background: Irritable bowel syndrome (IBS) is the most frequently diagnosed functional
gastrointestinal disorder. It is characterised by abdominal pain, bloating and changes in …

What is known and Objective: The complexity and diversity of irritable bowel syndrome's
(IBS) presentation make treatment difficult. Although there are reviews and guidelines for …

Irritable bowel syndrome with diarrhea (IBS-D) is a common, chronic functional
gastrointestinal disorder with symptoms that can be distressing for patients and often result …

Background: The global prevalence of Irritable bowel syndrome (IBS) is estimated to be as
high as 15% and a number of different non-pharmacological and pharmacological …

Irritable bowel syndrome (IBS) is a highly prevalent medical condition that adversely affects
patient quality of life and constitutes a significant economic burden on healthcare resources …

Introduction Irritable bowel syndrome (IBS) has a significant impact on society and quality of
life. Current treatments are ineffective, and new investigational drugs are necessary. Areas …